Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$0.6 - $1.07 $27,480 - $49,006
-45,800 Reduced 46.69%
52,300 $31,000
Q1 2024

May 15, 2024

BUY
$0.61 - $1.7 $2,074 - $5,780
3,400 Added 3.59%
98,100 $106,000
Q4 2023

Feb 14, 2024

BUY
$0.88 - $1.9 $2,992 - $6,460
3,400 Added 3.72%
94,700 $96,000
Q3 2023

Nov 14, 2023

SELL
$1.76 - $2.93 $7,392 - $12,306
-4,200 Reduced 4.4%
91,300 $188,000
Q2 2023

Aug 14, 2023

SELL
$2.26 - $4.36 $53,335 - $102,896
-23,600 Reduced 19.82%
95,500 $227,000
Q1 2023

May 15, 2023

SELL
$1.69 - $3.45 $126,581 - $258,405
-74,900 Reduced 38.61%
119,100 $410,000
Q4 2022

Feb 14, 2023

SELL
$1.61 - $3.04 $132,664 - $250,496
-82,400 Reduced 29.81%
194,000 $347,000
Q3 2022

Nov 14, 2022

BUY
$2.9 - $5.66 $89,320 - $174,328
30,800 Added 12.54%
276,400 $815,000

Others Institutions Holding DNMR

About Danimer Scientific, Inc.


  • Ticker DNMR
  • Exchange NYSE
  • Sector Basic Materials
  • Industry Specialty Chemicals
  • Shares Outstandng 101,176,000
  • Market Cap $34.4M
  • Description
  • Danimer Scientific, Inc., a performance polymer company, develops, produces, and provides bioplastic replacements for traditional petroleum-based plastics. It produces polyhydroxyalkanoate, a biodegradable plastic feedstock alternative used in a range of plastic applications, including films, straws, food containers, and other things under the N...
More about DNMR
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.